These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26050796)

  • 81. Study on a novel polymorphism in the VKORC1 promoter region using bioinformatic tools and warfarin dosing data.
    Askari B; Khaleqsefat E; Khalafkhani D; Khalaj-Kondori M; Khademvatan K; Soraya H
    Thromb Res; 2017 Oct; 158():76-78. PubMed ID: 28846878
    [No Abstract]   [Full Text] [Related]  

  • 82. Genetic warfarin dosing: tables versus algorithms.
    Finkelman BS; Gage BF; Johnson JA; Brensinger CM; Kimmel SE
    J Am Coll Cardiol; 2011 Feb; 57(5):612-8. PubMed ID: 21272753
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evolutionary Ensemble Learning Algorithm to Modeling of Warfarin Dose Prediction for Chinese.
    Tao Y; Chen YJ; Fu X; Jiang B; Zhang Y
    IEEE J Biomed Health Inform; 2019 Jan; 23(1):395-406. PubMed ID: 29993619
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genotype vs Clinically Guided Dosing of Warfarin to Prevent Adverse Events.
    Han-You X
    JAMA; 2018 Mar; 319(12):1278-1279. PubMed ID: 29584834
    [No Abstract]   [Full Text] [Related]  

  • 85. Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study).
    Filippelli A; Signoriello S; Bancone C; Corbi G; Manzo V; Iesu S; Politi C; Gigantino A; De Donato MT; Masiello P; Simeon V; Della Corte A; Cellurale M; Conti V; Frigino M; Ciarambino T; Marracino M; Carpenito L; Ferrara N; De Feo M; Gallo C
    Pharmacogenomics J; 2020 Jun; 20(3):451-461. PubMed ID: 31801992
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dosage individualization of warfarin using artificial neural networks.
    Saleh MI; Alzubiedi S
    Mol Diagn Ther; 2014 Jun; 18(3):371-9. PubMed ID: 24574079
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Validation and comparison between two warfarin dosing clinical algorithms and warfarin fixed dosing in specialized heart center: cross-sectional study.
    Elnour AA; Ahmed IM; Khalid AK; Elmustafa M
    Pharm Pract (Granada); 2022; 20(3):2722. PubMed ID: 36733524
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of the predictive abilities of pharmacogenetics-based warfarin dosing algorithms using seven mathematical models in Chinese patients.
    Li X; Liu R; Luo ZY; Yan H; Huang WH; Yin JY; Mao XY; Chen XP; Liu ZQ; Zhou HH; Zhang W
    Pharmacogenomics; 2015; 16(6):583-90. PubMed ID: 25872772
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A review of a priori regression models for warfarin maintenance dose prediction.
    Francis B; Lane S; Pirmohamed M; Jorgensen A
    PLoS One; 2014; 9(12):e114896. PubMed ID: 25501765
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation of Stable Doses of Warfarin in a Patient Cohort.
    Sridharan K; Banny RA; Husain A
    Drug Res (Stuttg); 2020 Dec; 70(12):570-575. PubMed ID: 32820470
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Estimation and validation of acenocoumarol dosing algorithms in Bulgarian patients with cardiovascular diseases.
    Tzveova R; Dimitrova-Karamfilova A; Saraeva R; Solarova T; Naydenova G; Petrova I; Hristova N; Popov I; Nachev G; Mitev V; Kaneva R
    Per Med; 2015 Jun; 12(3):209-220. PubMed ID: 29771648
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pharmacogenetic Implementation Lessons From the "Real World".
    Roden DM
    Clin Pharmacol Ther; 2017 Jul; 102(1):25-27. PubMed ID: 27981579
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans.
    Steiner HE; Giles JB; Patterson HK; Feng J; El Rouby N; Claudio K; Marcatto LR; Tavares LC; Galvez JM; Calderon-Ospina CA; Sun X; Hutz MH; Scott SA; Cavallari LH; Fonseca-Mendoza DJ; Duconge J; Botton MR; Santos PCJL; Karnes JH
    Front Pharmacol; 2021; 12():749786. PubMed ID: 34776967
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacogenetics in the brazilian population.
    Suarez-Kurtz G
    Front Pharmacol; 2010; 1():118. PubMed ID: 21833165
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment.
    Belley-Côté EP; Whitlock RP; French B; Evaniew N; Kimmel SE
    Thromb Res; 2015 Jul; 136(1):180-1. PubMed ID: 26004747
    [No Abstract]   [Full Text] [Related]  

  • 96. Systematic review of pharmacogenetic warfarin dosing.
    van Schie RM; Jorgensen AL; de Boer A; Maitland-van der Zee AH;
    J Gen Intern Med; 2009 Oct; 24(10):1171. PubMed ID: 19693633
    [No Abstract]   [Full Text] [Related]  

  • 97. Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time.
    Eby CS
    Clin Chem; 2009 Apr; 55(4):712-4. PubMed ID: 19233915
    [No Abstract]   [Full Text] [Related]  

  • 98. A systematic approach to warfarin dosing using a decision-making algorithm.
    Cherpak C
    J Am Acad Nurse Pract; 1994 Oct; 6(10):485-8. PubMed ID: 7848737
    [No Abstract]   [Full Text] [Related]  

  • 99. Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII.
    Yildirim E; Erol K; Birdane A
    Hippokratia; 2014; 18(4):319-27. PubMed ID: 26052198
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
    Cho SM; Lee KY; Choi JR; Lee KA
    Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.